BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Lone Star Bio

  Opexa Therapeutics to Participate at Upcoming Industry Conferences

  September 10, 2012

   · 

  1 min read
• Deals

  Biogen Idec, Inc. (Massachusetts) Sells BENLYSTA Royalty Rights to DRI Capital Managed Fund

  September 10, 2012

   · 

  1 min read
• Drug Development

  Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial

  September 10, 2012

   · 

  4 min read
• Genetown

  BIND Biosciences, Inc. to Present at UBS Global Life Sciences Conference

  September 10, 2012

   · 

  1 min read
• Drug Development

  Compugen Ltd. Drug Candidate Demonstrates Attenuation of Autoimmunity and Reestablishment of Immune Balance

  September 10, 2012

   · 

  1 min read
• Genetown

  Charles River Laboratories (Massachusetts) to Present at Morgan Stanley Healthcare Conference

  September 10, 2012

   · 

  1 min read
• Business

  Osmotica Pharmaceutical Announces the Appointment of Darren Alkins as Executive Vice President

  September 10, 2012

   · 

  1 min read
• Drug Development

  NanoViricides, Inc. Reports Its Oral FluCide® Anti-Influenza Drug Candidates Are Superior to Oral Oseltamivir (TamiFlu®) in H1N1 Influenza Lethal Infection Model

  September 10, 2012

   · 

  1 min read
• Business

  Dart Therapeutics Appoints Executive Team

  September 10, 2012

   · 

  4 min read
• Genetown

  Bruker Corporation Announces New Quantitative Proteomics Capabilities With Skyline Software

  September 10, 2012

   · 

  1 min read